Healthcare M&A Japan
-
Japan’s Medical Device Industry and M&A: A USD 31.5 Billion Market and Global Players Emerging from Kansai
Japan’s medical device sector directly supports human health and life across diagnosis, treatment, monitoring and prevention. The domestic market has reached nearly USD 33 billion, while Kansai, particularly Kobe and Osaka, has developed into a major cluster of internationally active companies, including Sysmex, Nipro and Daiken Medical. Japan also has several hundred independent and semi-independent…
-
Japan’s Pharmaceutical and Medical Supplies Distribution Sector and M&A: Consolidation Under Drug-Pricing Reform, Generic Supply Disruption and Activist Pressure
Japan’s pharmaceutical and medical supplies distribution sectors form a critical part of the country’s healthcare supply chain, yet they face a combination of structural pressures that are not always visible from outside Japan. According to the Federation of Japan Pharmaceutical Wholesalers Associations’ Pharmaceutical Wholesalers Association Guide 2025, pharmaceutical sales by its member companies totaled USD…